Literature DB >> 11176386

The prediction of papaverine induced priapism by color Doppler sonography.

M Secil1, D Arslan, A Y Goktay, A A Esen, O Dicle, T Pirnar.   

Abstract

PURPOSE: We identified color Doppler sonography findings that are useful for predicting priapism in patients after the intracavernous injection of diagnostic papaverine.
MATERIALS AND METHODS: We evaluated 72 men with erectile dysfunction by color Doppler sonography after the diagnostic injection of papaverine. Cavernous artery waveforms were recorded, and peak systolic and diastolic velocity of the recorded waveforms was measured. In cases of priapism color Doppler sonography findings were retrospectively evaluated to identify any finding that would predict priapism.
RESULTS: Priapism was observed in 8 of the 72 patients (11.1%). In 6 of 8 priapism cases there was no blood flow in the cavernous artery during or after adequate erection, including after minutes 5, 10 and 20 in 3, 1 and 2, respectively. This absence of encoding was not relieved even after all stimuli were removed. In 2 patients who later presented with complaints of priapism the Doppler study was completed normally and all parameters were acquired without any cessation of blood flow in the cavernous artery. The persistent disappearance of color and pulse encoding in the cavernous artery predicted priapism with 75% sensitivity, 100% specificity, a positive and negative predictive value of 100% and 96.9%, respectively, and 97% accuracy.
CONCLUSIONS: The persistence of absent blood flow in the cavernous artery even after the elimination of all stimuli during penile color Doppler ultrasound is a reliable predictor of priapism. The finding is accurate enough to initiate treatment for priapism to avoid further delay.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176386     DOI: 10.1097/00005392-200102000-00015

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Thrombosis and priapism in a patient with Henoch-Schonlein purpura.

Authors:  Ismail Sari; Servet Akar; Mustafa Secil; Merih Birlik; Aykut Kefi; Fatos Onen; Ilhan Celebi; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

2.  Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.

Authors:  J Hübler; A Szántó; K Könyves
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 3.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

4.  Colour Doppler ultrasound hemodynamic characteristics of patients with priapism before and after therapeutic interventions.

Authors:  Rei K Chiou; Himanshu Aggarwal; Christopher R Chiou; Fleur Broughton; Susan Liu
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

5.  Is there a relation between priapism occurring after penile doppler ultrasonography and international erectile function index score and erection hardness score levels?

Authors:  Mehmet Giray Sönmez; Ahmet Öztürk
Journal:  Turk J Urol       Date:  2017-12-01

Review 6.  Recent advances in the management of priapism.

Authors:  Asif Muneer; Hussain M Alnajjar; David Ralph
Journal:  F1000Res       Date:  2018-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.